Search for: "MYLAN INC." Results 201 - 220 of 673
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2016, 2:01 pm by Susanna Leighton
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of The post EpiFail: Gov’t Knew EpiPen Was Misclassified in 2009 appeared first on Legal… [read post]
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
3 Apr 2013, 4:45 am by Eric Guttag
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
4 Jun 2012, 9:55 pm by Patent Docs
Mylan Pharmaceuticals, Inc. et al. 8:12-cv-01190; filed May 25, 2012 in the Middle District... [read post]
3 Mar 2012, 9:45 am by Lawrence B. Ebert
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE;… [read post]
24 Mar 2008, 5:09 am
We don't usually report on labor and employment cases in this space.Heck, we don't usually read labor and employment cases.But the recent decision in Mylan Pharmaceuticals , Inc. v. [read post]
18 Aug 2014, 6:48 am by Gregory B. Williams
Mylan Pharmaceuticals, Inc., et al., Civil Action No. 08-889-SLR (D.Del., August 14, 2014), the Court granted defendants’ motion for partial summary judgment of no willfulness with respect to their infringement of the patents-in-suit based upon defendants’ at risk launch of their generic versions of plaintiffs’ Amrix® products. [read post]
5 Dec 2017, 7:40 am by Sarah M Donnelly
Here are the amici curiae in the matter of Mylan Pharmaceuticals Inc. et al v. [read post]
5 Aug 2021, 7:38 pm by Patent Docs
The product is Semglee (insulin glargine-yfgn), produced by Mylan Pharmaceuticals, Inc., and under this approval, it is interchangeable with Lantus (insulin glargine) made by Sanofi. [read post]